111 to build a disease management platform with Bayer
Chinese healthcare platform 111 has expanded its existing partnership with global drug maker Bayer Healthcare Co.
The two companies first entered into a strategic partnership last year in September to market innovative drugs and healthcare products for chronic disease management. A digital platform was also built to provide online pharmacist...
Nasdaq-listed 111, a Chinese healthcare platform, has entered into a strategic cooperation agreement with Jiangsu-based drug R&D firm Suzhou Zelgen Biopharmaceuticals Co. to build a virtual platform for liver cancer patients.
WHAT IT DOES
111 operates an internet hospital offering virtual health consultations, an electronic prescription service, and a patient management service. It also runs...
09:50 pm
February 7, 2021
Chinese digital health company 111, Inc. ("111" or the "Company") inked a deal with physician group Jilin Baiyi Doctor Group Management ("Baiyi Doctor Group"), which operates in China's Jilin province, in order to incorporate the former's doctor-patient communication and healthcare management platform to the ladder's organization. As part of the partnership Jilin Baiyi Doctor Group Management...
09:40 pm
December 22, 2020
111, Inc. a leading digital healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced the successful completion of new capital injection in its principal PRC subsidiary by a selected group of strategic and mission-driven investors.
On December 22, 2020, 1 Pharmacy Yaofang Technology (Shanghai) Co., Ltd. (previously known...
